Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
180.03
1.59 (0.89%)
At close: Aug 15, 2025, 2:15 PM
Quest Diagnostics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 990M | 922M | 895M | 865M | 865M | 886M | 895M | 819M | 858M | 859M | 1.01B | 1.31B | 1.56B | 1.96B | 2.08B | 2.28B | 2.34B | 1.88B |
Depreciation & Amortization | 543M | 517M | 493M | 467M | 453M | 448M | 439M | 446M | 443M | 438M | 437M | 427M | 420M | 413M | 408M | 400M | 388M | 377M |
Stock-Based Compensation | 89M | 88M | 88M | 80M | 79M | 75M | 77M | 80M | 80M | 83M | 77M | 74M | 77M | 79M | 79M | 94M | 105M | 101M |
Other Working Capital | 11M | -64M | -48M | -65M | -61M | -1M | -64M | -2M | 5M | -76M | 22M | -15M | -23M | 104M | -9M | 18M | 22M | 17M |
Other Non-Cash Items | 97M | 88M | 100M | 76M | 86M | 65M | 55M | 43M | 35M | 67M | 69M | 33M | -19M | -360M | -366M | -378M | -388M | -66M |
Deferred Income Tax | 23M | 4M | -21M | -31M | -69M | -63M | -49M | -83M | 5M | 40M | 1M | 75M | 12M | -83M | -57M | -14M | -27M | 54M |
Change in Working Capital | -64M | -125M | -221M | -60M | -166M | -79M | -145M | -226M | -47M | -155M | 119M | -56M | -129M | -30M | 87M | -87M | 174M | 138M |
Operating Cash Flow | 1.68B | 1.49B | 1.33B | 1.4B | 1.25B | 1.33B | 1.27B | 1.08B | 1.37B | 1.33B | 1.72B | 1.86B | 1.92B | 1.98B | 2.23B | 2.29B | 2.59B | 2.49B |
Capital Expenditures | -454M | -438M | -425M | -374M | -373M | -385M | -408M | -483M | -496M | -468M | -404M | -401M | -372M | -380M | -403M | -421M | -423M | -421M |
Cash Acquisitions | -1.93B | -2.02B | -2.16B | -1.78B | -250M | -722M | -611M | -649M | -647M | -70M | -144M | -186M | 549M | 319M | 424M | 503M | -333M | -222M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5M | -6M | -6M | -6M | -4M | -10M | -18M | -19M | -19M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 6M | 6M | 6M | 85M | 84M | 246M | 337M | 253M |
Other Investing Acitivies | 13M | 10M | 41M | -5M | -11M | -9M | -42M | 11M | 11M | 6M | 5M | -9M | -751M | -75M | -74M | -230M | 421M | -250M |
Investing Cash Flow | -2.37B | -2.45B | -2.55B | -2.16B | -634M | -1.12B | -1.06B | -1.12B | -1.13B | -532M | -543M | -596M | -574M | -55M | 21M | 80M | -17M | -659M |
Debt Repayment | 1.46B | 1.16B | 1.54B | 2.02B | 128M | 748M | 748M | 276M | 318M | -1M | -2M | -1M | -2M | -2M | -2M | -554M | -554M | -5M |
Common Stock Repurchased | -151M | -151M | -151M | -275M | -288M | -310M | -310M | -496M | -857M | -1.03B | -1.41B | -1.24B | -862M | -2.16B | -2.2B | -2.16B | -2.16B | -660M |
Dividend Paid | -342M | -336M | -331M | -327M | -323M | -319M | -314M | -309M | -307M | -305M | -305M | -307M | -305M | -308M | -309M | -307M | -307M | -301M |
Other Financial Acitivies | -244M | -35M | -29M | -81M | -27M | -83M | -24M | -46M | -107M | -21M | -17M | -12M | 9M | -13M | -70M | -10M | 16M | 24M |
Financial Cash Flow | 746M | 676M | 1.08B | 1.38B | -469M | 83M | 160M | -515M | -906M | -1.34B | -1.73B | -1.56B | -1.12B | -2.44B | -2.54B | -2.99B | -3B | -942M |
Net Cash Flow | 48M | -286M | -137M | 621M | 145M | 299M | 371M | -557M | -664M | -537M | -557M | -287M | 230M | -518M | -286M | -618M | -428M | 888M |
Free Cash Flow | 1.22B | 1.06B | 909M | 1.02B | 875M | 947M | 864M | 596M | 878M | 864M | 1.31B | 1.46B | 1.55B | 1.6B | 1.83B | 1.87B | 2.17B | 2.07B |